Brought to you by

Tengion gets $54mm through its Series C round
29 Dec 2009
Executive Summary
Tengion (regenerative medicine) has raised $33mm through the closing of its Series C venture round. New investor Deerfield Partners was joined by returning backers Bain Capital, J&J Development Corp., HealthCap, Quaker BioVentures, Oak Investment Partners, and L Capital Partners. Tengion's current lenders, Horizon Technology and Oxford Finance, also made equity investments.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com